|
Volumn 43, Issue 3, 2009, Pages 349-359
|
Emerging markets and emerging agencies: A comparative study of how key regulatory agencies in Asia, Latin America, the Middle East, and Africa are developing regulatory processes and review models for new medicinal products
|
Author keywords
Asia, Latin America, Middle East, and Africa; Emerging markets; New medicines; Quality measures; Regulatory review
|
Indexed keywords
NEW DRUG;
ARGENTINA;
BRAZIL;
CHINA;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MARKETING;
EGYPT;
GOOD MANUFACTURING PRACTICE;
INDIA;
INDONESIA;
INFORMATION PROCESSING;
MALAYSIA;
MEXICO;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
QUALITY CONTROL;
REVIEW;
RISK ASSESSMENT;
SAUDI ARABIA;
SINGAPORE;
SOUTH AFRICA;
SOUTH KOREA;
TAIWAN;
TOTAL QUALITY MANAGEMENT;
|
EID: 67549137555
PISSN: 00928615
EISSN: None
Source Type: Journal
DOI: 10.1177/009286150904300314 Document Type: Review |
Times cited : (33)
|
References (4)
|